3 citations
,
June 2005 in “Ophthalmology Clinics of North America” Follicular unit transplantation treats hair loss and restores eyebrows with short recovery and natural results.
2 citations
,
January 2017 Minoxidil and Propecia are the only FDA-approved hair growth drugs, but people are exploring herbal alternatives due to concerns about side effects.
2 citations
,
November 2015 in “Journal of Investigative Dermatology Symposium Proceedings” A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.
2 citations
,
September 2007 Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.
September 2025 in “Journal of the American Academy of Dermatology” Low-dose oral minoxidil may be a promising alternative to topical minoxidil for hair loss.
November 2023 in “International journal of Ayurveda and pharma research” The herbal hair oil effectively promotes hair growth, nourishes the scalp, and prevents dandruff.
January 2012 in “Human health handbooks” Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.
August 2025 in “SSP Modern Pharmacy and Medicine” Effective alopecia treatments exist, but high costs and limited access remain challenges.
August 2025 in “Journal of the American Academy of Dermatology” Minoxidil can temporarily increase hair shedding, causing anxiety and treatment discontinuation.
July 2025 in “Journal of Investigative Dermatology” Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.
May 2025 in “Frontiers in Pharmacology” New treatments are needed for non-scarring alopecia due to current limitations.
May 2025 in “Italian Journal of Dermatology and Venereology” Start with minoxidil and finasteride for male hair loss; other options exist if needed.
July 2024 in “European Journal of Medicinal Chemistry” New small molecule drugs could help treat hair loss.
April 2023 in “Journal of Investigative Dermatology” Aminoacridine and Abemaciclib, especially combined with Minoxidil, show promise for treating hair loss.
January 2017 in “Touro Scholar (Touro College)” Hair loss can be managed and sometimes reversed with certain drugs, but not permanently cured.
April 2016 in “CRC Press eBooks” Biotechnology could lead to new hair growth products.
November 2002 in “International Society of Hair Restoration Surgery” Propecia is a top non-surgical treatment for hair loss, especially when combined with hair transplants.
January 2000 in “วารสารเภสัชวิทยา (Thai Journal of Pharmacology)” Early treatment with finasteride and minoxidil can effectively reverse hereditary hair loss.
Microneedling may be an effective treatment for pattern hair loss.
July 2022 in “Journal of Investigative Dermatology” Dermatologists can use social media to better educate people about hair loss treatments.
3 citations
,
November 2024 in “Clinical Research” Deuruxolitinib is FDA-approved for treating severe alopecia areata.
July 2003 in “Pediatrics in review” In 2001, the FDA approved 12 new drugs for children to treat allergies, asthma, ADHD, birth control, and other conditions.
March 2026 in “Korean Journal of Clinical Pharmacy” In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.
September 2024 in “Annals of Medicine and Surgery” Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.
January 2018 in “Springer eBooks” Lasers are FDA-approved for permanent hair reduction, not removal, and more research is needed to improve treatments.
4 citations
,
January 2010 Only finasteride and minoxidil are FDA-approved for male pattern hair loss.
September 2022 in “Hair transplant forum international” JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.
January 2005 in “Digital Access to Scholarship at Harvard (DASH) (Harvard University)” The FDA struggles to regulate hair loss supplements due to a law allowing unproven claims.
June 2022 in “C&EN global enterprise” The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.
1 citations
,
October 2022 in “Molecular therapy” The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.